Imaging intensiveclinical trials create a tremendous amount of data - several gigabytes per subject – and require storage for a minimum of seven years for regulatory compliance. To support the need for storage and streamlined access to data during and after a clinical trial, AG Mednet today announced AG Mednet Storage – a Part 11 compliant repository with on-demand access to clinical trial image data.
AG Mednet Storage is a complement to AG Mednet's quality enhancement products including AG Mednet Submission Quality & Compliance – the first automated quality assurance software built specifically to detect errors at the investigator site prior to data submission in order to reduce queries and accelerate clinical trial decision-making. Specific benefits of the AG Mednet Storage offering include:
For Sponsors
For Core Labs
For Academic Core Labs
Related Links:
ICON Medical Imaging Selects AG Mednet
For more information about the new AG Mednet storage module and to schedule a demonstration, please visit http://www.agmednet.com/clinical-trials-solutions/storage/.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.